ad image

Acquisition

1 / 1
Ampersand Capital Partners
Acquisition

Ampersand Capital Partners Aquired Nektar Therapeutics' PEG Reagent Manufacturing Business, Launching Newly Branded Gannet BioChem

Ampersand Capital Partners

PR-12-24-NI-121Dec 02, 2024
Boston Scientific
Axonics

Boston Scientific Closes Acquisition of Axonics, Inc.

Boston Scientific

PR-11-24-NI-105Nov 15, 2024
Vantage Solutions

Vantage Nutrition LLC Acquires ComboCap Inc

Vantage Solutions

PR-M03-23-07Mar 27, 2023
AcuraBio
Acquisition and Rebranding

Dr. Glenn Haifer and Ampersand Capital Partners Acquire Australian Biologics CDMO Luina Bio, Rebranding as AcuraBio

AcuraBio

PR-M09-22-01Sep 07, 2022
Novo Holdings A/S
M&A

Novo Holdings Portfolio Company ReViral to be Acquired by Pfizer

Novo Holdings A/S

PR-M04-22-05Apr 07, 2022
TriRx Pharmaceutical Services
M&A

TriRx Completes Acquisition of Elanco Manufacturing Facility in Speke, United Kingdom

TriRx Pharmaceutical Services

PR-M02-22-06Feb 08, 2022
Fujifilm Diosynth Biotechnologies
Facility Acquisition

Fujifilm Expands its Advanced Therapies CDMO Business with the Acquisition of a Dedicated Cell Therapy Manufacturing Facility from Atara Biotherapeutics, Inc.

Fujifilm Diosynth Biotechnologies

PR-M01-22-18Jan 26, 2022
TriRx Pharmaceutical Services
New Facility

TriRx Hosted State and Community Leaders to Celebrate Acquisition of Shawnee, Kansas Facility

TriRx Pharmaceutical Services

PR-M07-21-013Aug 11, 2021
TriRx Pharmaceutical Services
Acquisition

TriRx Completes Acquisition of Elanco Animal Health Facility in Shawnee, Kansas

TriRx Pharmaceutical Services

PR-M08-21-01Aug 02, 2021
TriRx Pharmaceutical Services
Facility Acquisition

TriRx Enters Agreement for the Acquisition of Elanco Animal Health Facilities in Shawnee, Kansas and Speke, United Kingdom

TriRx Pharmaceutical Services

PR-M06-21-019Jun 15, 2021
Grifols
Acquisition

Grifols Reinforces its Innovation Strategy After Completing the Acquisition of GigaGen to Boost a Novel Method to Generate a Wide Range of Immunoglobulins

Grifols

PR-M11-20-045Mar 09, 2021
WuXi AppTec

WuXi AppTec Completes Acquisition of OXGENE to Further Strengthen Cell and Gene Therapy Service Offerings for Global Customers

WuXi AppTec

PR-M11-20-040Mar 02, 2021
Thermo Fisher Scientific
Acquisition

Thermo Fisher Scientific Acquires Viral Vector Manufacturing Business from Novasep

Thermo Fisher Scientific

PR-M11-20-035Jan 15, 2021
AbCellera Biologics Inc.
M&A

AbCellera Expands Technology Stack with Acquisition of Trianni for $90 Million

AbCellera Biologics Inc.

PR-M11-20-018Nov 19, 2020
1 / 1